Dec 7 (Reuters) - UK’s Competition and Markets Authority (CMA)
* Fines Pfizer and Flynn 90 million stg for drug price hike to NHS
* Imposed a 84.2 million stg fine on Pfizer, and 5.2 million stg fine on the distributor Flynn Pharma
* Fines companies after finding that each broke competition law by charging excessive, unfair prices in UK for phenytoin sodium capsules
* Fines follow prices increasing by up to 2,600 percent overnight after the drug was deliberately de-branded in September 2012
* To ensure no risk to ongoing supply of phenytoin sodium capsules CMA has given companies between 30 working days and 4 months to cut prices
* Has also ordered the companies to reduce their prices.
* "Prices of the drug in the UK have also been many times higher than Pfizer's prices for the same drug in any other European countries" Source text: (bit.ly/2h55sCr) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)